company background image
SILK

Silk Road Medical NasdaqGS:SILK Stock Report

Last Price

US$31.64

Market Cap

US$1.2b

7D

4.8%

1Y

-16.2%

Updated

07 Jun, 2023

Data

Company Financials +

SILK Stock Overview

Silk Road Medical, Inc. operates as a medical device company in the United States.

SILK fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Silk Road Medical, Inc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Silk Road Medical
Historical stock prices
Current Share PriceUS$31.64
52 Week HighUS$58.04
52 Week LowUS$28.98
Beta1.18
1 Month Change-26.33%
3 Month Change-29.01%
1 Year Change-16.16%
3 Year Change-18.93%
5 Year Changen/a
Change since IPO-12.55%

Recent News & Updates

Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

May 05
Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

Recent updates

Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

May 05
Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price

Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Apr 04
Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?

Silk Road Medical announces $100M common stock offering

Oct 17

Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Sep 24
Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M

Jul 26

Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture

Jul 19

Silk Road Medical falls after Citigroup downgrades to Sell from Neutral

Jul 11

Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Jun 09
Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?

Silk Road Medical - What A Road It Has Been

Apr 08

Is Silk Road Medical (NASDAQ:SILK) Using Debt Sensibly?

Feb 23
Is Silk Road Medical (NASDAQ:SILK) Using Debt Sensibly?

Silk Road Medical, Inc's (NASDAQ:SILK) Intrinsic Value Is Potentially 48% Above Its Share Price

Jan 24
Silk Road Medical, Inc's (NASDAQ:SILK) Intrinsic Value Is Potentially 48% Above Its Share Price

Is It Too Late To Consider Buying Silk Road Medical, Inc (NASDAQ:SILK)?

Dec 09
Is It Too Late To Consider Buying Silk Road Medical, Inc (NASDAQ:SILK)?

Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Nov 18
Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Is There An Opportunity With Silk Road Medical, Inc's (NASDAQ:SILK) 48% Undervaluation?

Sep 03
Is There An Opportunity With Silk Road Medical, Inc's (NASDAQ:SILK) 48% Undervaluation?

Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

May 07
Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?

Shareholder Returns

SILKUS Medical EquipmentUS Market
7D4.8%0.9%2.6%
1Y-16.2%3.3%2.1%

Return vs Industry: SILK underperformed the US Medical Equipment industry which returned 2.8% over the past year.

Return vs Market: SILK underperformed the US Market which returned 1.3% over the past year.

Price Volatility

Is SILK's price volatile compared to industry and market?
SILK volatility
SILK Average Weekly Movement7.3%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.7%
10% most volatile stocks in US Market15.9%
10% least volatile stocks in US Market3.1%

Stable Share Price: SILK is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: SILK's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2007414Erica Rogershttps://silkroadmed.com

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure.

Silk Road Medical, Inc Fundamentals Summary

How do Silk Road Medical's earnings and revenue compare to its market cap?
SILK fundamental statistics
Market CapUS$1.16b
Earnings (TTM)-US$54.79m
Revenue (TTM)US$150.75m

8.1x

P/S Ratio

-22.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SILK income statement (TTM)
RevenueUS$150.75m
Cost of RevenueUS$41.83m
Gross ProfitUS$108.92m
Other ExpensesUS$163.71m
Earnings-US$54.79m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.41
Gross Margin72.26%
Net Profit Margin-36.35%
Debt/Equity Ratio47.5%

How did SILK perform over the long term?

See historical performance and comparison